clinical trial · NCT07728097
A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS
Lennox-Gastaut SyndromeCannabidiol Oral Solution
brief summary
This is a Phase 3b/Phase 4 study. The purpose of this study is to learn more about the efficacy of using CBD-OS as an add-on therapy for the treatment of LGS in adults.
started
Nov 18, 2026
primary completion
Dec 28, 2028
completion
Dec 28, 2028
last updated
Oct 22, 2026
official title
A Phase 3b/4, Interventional, Prospective, Multicenter, Open-Label Study Evaluating the Effectiveness of a Gradual Titration Regimen to Optimize CBD-OS as Add-On Therapy in Adults With Lennox-Gastaut Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol